Companies

See how salaries can vary from company to company

InfuCare Rx is a leading data driven nationwide specialty infusion therapy provider focused on treating patients with chronic conditions who require comprehensive clinical management services. Today, many chronic conditions require specialized infusion therapies to help patients lead a healthy and productive lifestyle. InfuCare Rx provides a consistent, coordinated infusion experience for patients in the convenience of their home or alternate care setting. Our dedicated team of pharmacists, nurses and other trained professionals strive to provide optimal patient outcomes through cost effective... view company details

Krystal Biotech, Inc., a gene therapy company, develops and commercializes pharmaceutical products for patients suffering from dermatological diseases in the United States. The company's lead product candidate is KB103, which is in Phase II of a Phase I/II clinical study to treat dystrophic epidermolysis bullosa, a genetic disease. It is also involved in developing KB105 that is in preclinical studies for treating patients with deficient autosomal recessive congenital ichthyosis. The company was formerly known as Krystal Biotech, LLC and changed its name to Krystal Biotech, Inc. in March 2017.... view company details

Zafgen, Inc., a clinical-stage biopharmaceutical company, develops therapies for patients suffering from metabolic diseases comprising type 2 diabetes, Prader-Willi syndrome (PWS), and liver diseases. Its lead product candidate is ZGN-1061, a fumagillin-class methionine aminopeptidase 2 (MetAP2) inhibitor administered by subcutaneous injection, which is in Phase II clinical trial and profiled for its utility in the treatment of type 2 diabetes and other related metabolic disorders. The company also develops ZGN-1258, a MetAP2 inhibitor for treatment of PWS; and ZGN-1345, an orally dosed MetAP2... view company details

LGK is a statewide movement to make Vermont the best place to raise a family and our mission is to ensure affordable access to high-quality child care for all Vermont families by 2025. We work with our partners throughout the state to build high-quality child care and we're calling for more public investment in child care so that it's affordable for families. Together, we will make historic change that will lead to opportunity for our children, families and Vermont's future. view company details

Life.Church is one church in multiple locations, meeting across the United States and globally at Church Online. Our mission is to lead people to become fully devoted followers of Christ. We are risk-taking, irrationally generous, spiritual contributors who bring our best, laugh hard, and honor God with integrity. Visit www.life.church/careers to learn more about the hiring process, take a look at our benefits, and see what it's like to work at Life.Church. view company details

The Los Angeles Homeless Services Authority (LAHSA) is a joint powers authority of the city and county of Los Angeles, created in 1993 to address the problem of homelessness in Los Angeles County. LAHSA is the lead agency in the HUD-funded Los Angeles Continuum of Care, and coordinates and manages over $300 million annually in federal, state, county, and city funds for programs providing shelter, housing, and services to people experiencing homelessness. Apply online for a job in homeless services: https://www.lahsa.org/jobs view company details

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company's lead candidate is MGL-3196, an orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) ss-selective agonist, which is in Phase II clinical trials for the treatment of non-alcoholic steatohepatitis and heterozygous familial hypercholesterolemia. It is also developing MGL-3745, a THR-ss-selective small molecule that is in preclinical trial... view company details

Outlook Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics in immunology and oncology disease areas. Its lead clinical program is ONS-5010, a proprietary ophthalmic bevacizumab product candidate that is in Phase I clinical trial for the treatment of wet age related macular degeneration. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in December 2018. The company was founded in 2010 and is headquartered in Cranbury, New Jer... view company details

Welcome to the LinkedIn page of the Oklahoma Department of Human Services! Follow this page for information about career opportunities and news about DHS. Our mission: We improve the quality of life of vulnerable Oklahomans by increasing people's ability to lead safer, healthier, more independent and productive lives. Our vision: DHS provides help and offers hope to vulnerable Oklahomans through stronger practices, involved communities and a caring and engaged workforce. See our current career opportunities at the following link: https://www.jobapscloud.com/OK/?Keyword=&Loc=&DeptNumber=830000&... view company details

Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidates include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis; and novel anthrax vaccine candidates, such as Px563L and RPA563 that have completed Phase Ia clinical study. The company also develops PF582, a biosimilar candidate to Lucentis; PF529, a biosimilar to Neulasta; and hematology/oncology products, including PF743, a recombinant crisantaspase, as well as PF745, a re... view company details

PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed ... view company details

Protalex, Inc. focuses on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases in the United States. The company targets a range of autoimmune diseases, such as rheumatoid arthritis (RA), immune thrombocytopenia (ITP), psoriasis, myasthenia gravis, chronic idiopathic demyelinating polyneuropathy, and pemphigus. Its lead product candidate is PRTX-100, an immunomodulatory therapy, a highly-purified form of staphylococcal protein A, which is in Phase I/II open-label, dose-escalating study for the treatment of patients with persistent/chronic ITP; and Phase ... view company details

At Potential Inc. our vision is for every person with autism to lead a successful life of value. Our mission as a non-profit organization is to assist children and adults with autism to reach their full educational, social and emotional potential by developing and applying innovative, evidence-based approaches. Potential, Inc. is dedicated to providing high-quality direct services, consultation, community outreach and education for families and professionals. We serve ages 1-64 in our clinic, school, and in the community, schools, and homes. view company details

Ritter Pharmaceuticals, Inc. develops and sells therapeutic products that modulate the gut microbiome to treat digestive disorders and gastrointestinal diseases. Its lead product candidate is RP-G28, an orally administered galacto-oligosaccharide that is in Phase III clinical trials for the treatment of lactose intolerance. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California. view company details

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary subcutaneous formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients outside of the acute care setting. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for t... view company details

Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; and in Phase IIa development stage for treating nontuberculous mycobacterial lung infection. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III stage for the treatment of methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis. Savara Inc. is headquarte... view company details

Solitario Zinc Corp., an exploration stage company, engages in the acquisition, exploration, and development of zinc properties in North and South America. It primarily owns a 39% interest in the Florida Canyon zinc project located in northern Peru; and a 50% interest in the Lik zinc-lead-silver property located in Northwest Alaska. The company also owns the La Promesa gold exploration project; and an 85% interest in the Chambara exploration project located in Peru. The company was formerly known as Solitario Exploration & Royalty Corp. and changed its name to Solitario Zinc Corp. in July 2017... view company details

South Puget Sound Community College supports student success and builds prosperity by collaborating with leaders in industry, education, and our community to offer innovative, accessible, and affordable learning experiences. We employ devoted people who mirror the diversity of our community and contribute to an inclusive, welcoming environment. By investing in the creativity of our staff and faculty, we construct clear and compelling pathways that lead our students to successful outcomes on their educational journeys. We are fiscally strong and our mindful use of technology embedded in purpose... view company details

Welcome! We in Maine take pride in our quality of life, our entrepreneurial spirit, and our strong, independent heritage. Our motto'"Dirigo" or "I lead" ' reflects our sense of place, as the first state that greets the sun each morning, as well as our sense of pride…pride in our craftsmanship, our work ethic and our people. No matter where you work in Maine you find a real sense of authenticity. From our small cities to our rural communities, Maine offers a skilled and committed workforce, an unmatched transportation and information technology infrastructure, and an open-for-business attitude ... view company details

At Thomas Industrial Coatings, we take tremendous pride in every single service we offer - concrete coatings, fireproofing, industrial coating applications and lead abatement just to name a few. There's never a scenario we're uncomfortable with - just look at all the markets we've served and the services we offer. Our home office is in Pevely, Missouri (south of St. Louis) and we have satellite offices throughout the country. We've worked in almost every state and we have more than $9 million in state-of-the-art equipment. To sum it up, we can work anywhere and on anything. As our owner himsel... view company details